0001420506-20-000824.txt : 20200807 0001420506-20-000824.hdr.sgml : 20200807 20200806201855 ACCESSION NUMBER: 0001420506-20-000824 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200807 DATE AS OF CHANGE: 20200806 EFFECTIVENESS DATE: 20200807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RHO CAPITAL PARTNERS INC CENTRAL INDEX KEY: 0001020455 IRS NUMBER: 133087622 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-05883 FILM NUMBER: 201083469 BUSINESS ADDRESS: STREET 1: 152 WEST 57TH STREET STREET 2: 23RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2127516677 MAIL ADDRESS: STREET 1: 152 WEST 57TH STREET STREET 2: 23RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: RHO MANAGEMENT CO INC DATE OF NAME CHANGE: 19960806 13F-HR 1 primary_doc.xml 13F-HR LIVE false true false 0001020455 XXXXXXXX 06-30-2020 06-30-2020 false RHO CAPITAL PARTNERS INC

152 WEST 57TH STREET 23RD FLOOR NEW YORK NY 10019

13F HOLDINGS REPORT 028-05883 N Peter E. Kalkanis 2127516677 Peter E. Kalkanis, Chief Financial Officer NEW YORK NY 08-03-2020 0 5 154398 false INFORMATION TABLE 2 Form13F_InfoTable.xml INFORMATION TABLE FOR RHO CAPITAL PARTNERS INC CARA THERAPEUTICS INC COM 140755109 47864 2799058 SH SOLE 2799058 0 0 LIVEXLIVE MEDIA INC COM NEW 53839L208 13481 3724138 SH SOLE 3724138 0 0 MERSANA THERAPEUTICS INC COM 59045L106 18637 796458 SH SOLE 796458 0 0 NGM BIOPHARMACEUTICALS INC COM 62921N105 74354 3766666 SH SOLE 3766666 0 0 SENSEONICS HLDGS INC COM 81727U105 62 159601 SH SOLE 159601 0 0